| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3733217
Max Phase: Preclinical
Molecular Formula: C17H23BrN4O2S
Molecular Weight: 427.37
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CNCCNC(=O)[C@H]1[C@H](C(=O)Nc2ncc(Br)s2)[C@@H]2CC[C@H]1C21CC1
Standard InChI: InChI=1S/C17H23BrN4O2S/c1-19-6-7-20-14(23)12-9-2-3-10(17(9)4-5-17)13(12)15(24)22-16-21-8-11(18)25-16/h8-10,12-13,19H,2-7H2,1H3,(H,20,23)(H,21,22,24)/t9-,10+,12-,13-/m1/s1
Standard InChI Key: RBCVHTLZDDUSNT-LYIQGSDWSA-N
Associated Targets(Human)
FML2_HUMAN 519 Activities
Lipoxin A4 receptor 3472 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 427.37 | Molecular Weight (Monoisotopic): 426.0725 | AlogP: 2.23 | #Rotatable Bonds: 6 |
| Polar Surface Area: 83.12 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.88 | CX Basic pKa: 9.59 | CX LogP: 0.37 | CX LogD: -0.18 |
| Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: -0.43 |
References
| 1. (2012) Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists, |
Source
Source(1):